Free Trial
TSE:PRN

Profound Medical (PRN) Price, Holdings, & News

Profound Medical logo
C$9.64 -0.26 (-2.63%)
As of 03:59 PM Eastern

About Profound Medical (TSE:PRN)

Advanced

Key Stats

Today's Range
C$9.39
▼
C$10.00
50-Day Range
C$7.79
▼
C$9.99
52-Week Range
C$6.52
▼
C$12.40
Volume
9,300 shs
Average Volume
15,673 shs
Market Capitalization
C$352.25 million
Assets Under Management
C$131.70 million
Dividend Yield
5.91%
Net Expense Ratio
0.60%
Aggregate Rating
Moderate Buy

ETF Overview

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Profound Medical Expenses

TypePRNIndustrials ETFsEquity ETFsTSE ETFsAll ETFs
Management Fee0.50%0.50%0.57%0.65%0.53%
Other Expenses0.14%2.11%0.53%0.14%0.54%
Total Expense0.64%1.45%0.75%0.72%0.73%
Fee Waiver-0.04%-3.86%-0.67%-0.04%-0.67%
Net Expense0.60%0.56%0.63%0.70%0.60%
Receive PRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRN ETF News Headlines

The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
See More Headlines

PRN ETF - Frequently Asked Questions

Profound Medical's stock was trading at C$10.77 at the beginning of 2026. Since then, PRN stock has decreased by 10.5% and is now trading at C$9.64.

Profound Medical Corp. (TSE:PRN) announced its quarterly earnings data on Thursday, November, 5th. The company reported C($0.30) earnings per share for the quarter. The business had revenue of C$13.99 million for the quarter. Profound Medical had a negative trailing twelve-month return on equity of 62.45% and a negative net margin of 170.92%.

Shares of PRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Profound Medical investors own include CloudMD Software & Services (DOC), FuelCell Energy (FCEL), Air Canada (AC), Canadian Tire (CTC.A), Enbridge (ENB), Finning International (FTT) and Trisura Group (TSU).

Fund Details

Issuer
Invesco
Fund Name
Invesco DWA Industrials Momentum ETF
Tax Classification
Regulated Investment Company
Stock Exchange
TSE
Current Symbol
TSE:PRN
Inception Date
10/12/2006
Fund Manager
Peter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon

Fund Focus

Asset Class
Equity
Benchmark
DWA Industrials Technical Leaders Index
Category
Sector
Focus
Industrials
Development Level
Developed Markets
Region
North America
Number of Holdings
45

Fund Statistics

Assets Under Management
$131.70 million
Average Daily Volume
$18.99 thousand
Discount/Premium
-0.74%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Invesco Capital Management LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Invesco Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Susquehanna

Miscellaneous

Beta
1.40
Creation Unit
50,000
Creation Fee
$500.00
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Top 10 PRN Holdings

PRN Sector Exposure

PRN Industry Exposure


This page (TSE:PRN) was last updated on 11/5/2026 by MarketBeat.com Staff.
From Our Partners